Levodopa: the story so far

Abbott, Alison·2010·Nature
DOI 10.1038/466s6a

Cited by (111)

Items 101–111 of 111

  1. Flexible Electrodes for the Electroanalysis of Neurotransmitters
    Amir Sawires, Raphaël Trouillon · 2024 · IEEE Interregional NEWCAS Conference (NEWCAS)
  2. Targeting serum response factor (SRF) deactivates ΔFosB and mitigates Levodopa-induced dyskinesia in a mouse model of Parkinson’s disease
    Piniel Alphayo Kambey, Jiao Wu, Wenya Liu, Mingyu Su, Wokuheleza Buberwa, Chuanxi Tang · 2024 · Gene Therapy
  3. Novel 2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole derivatives as triple-target D2R/D3R/5-HT1AR agonists with robust antidepressant and antiparkinsonian activity
    Xin-Li Du, Xuyan Liu, Lei Li, Zijin Feng, Yisheng Zhong, Kun Luo, Zhijing Hu, Peng Xie, Guan Wang · 2025 · European Journal of Medicinal Chemistry
  4. Dopaminergic Therapies for Parkinson's Disease in Under-Resourced Settings
    Vibhas Mittra, Alka Bali, Bhawna · 2026 · IGI Global eBooks
  5. Semi-synthetic alkaloid vindeburnol: Synthesis and its effect on the central nervous system
    Lyudmila Borets, Yana Zorkina, Olga V. Abramova, Valeriya M. Ushakova, Eugene A. Zubkov, Vadim Makarov · 2026 · Studies in natural products chemistry
  6. Genetics of α-Synuclein: The Prime Pathological Player of Parkinson’s Disease
    Tanveera Rounaque Sarhadi, Neha Joshi, Atchaya Raveendran, Janhavee Shirish Panse, Shirisha Nagotu · 2026 · Neurotoxicity Research
  7. Modular Bio‐Integrated Materials and Devices for Advanced Theranostic Healthcare
    Zhenyou Ge, X Q Li, Bingbing Gao, Chwee Teck Lim, Yukun Ren · 2026 · Advanced Materials
  8. Immunolocalization of L-DOPA and differential MpPPO1–3 expression in the embryonic axis and cotyledons of germinating Mucuna pruriens var. utilis seeds
    Lorena López-Sánchez, Alberto Camas-Reyes, Ana Lilia Hernández-Orihuela, Agustino Martínez‐Antonio · 2026 · Plant Physiology and Biochemistry
  9. BindingDB Entry 50002808: Secondary carbamate linker can facilitate the sustained release of dopamine from brain-targeted prodrug.
    BindingDB · 2020 · UC San Diego
  10. BindingDB Entry 50033634: Identification of N-propylnoraporphin-11-yl 5-(1,2-dithiolan-3-yl)pentanoate as a new anti-Parkinson's agent possessing a dopamine D2 and serotonin 5-HT1A dual-agonist profile.
    BindingDB · 2012 · UC San Diego
  11. Utilization of Unusual Nonproteinogenic Amino Acids: A New Paradigm for Natural Products Drug Discovery
    Rohit Man Singh, Vikrant Nawal Vikram, Tadigoppula Narender · 2026 · ChemMedChem